BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18519758)

  • 21. SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.
    Cheng YY; Chang KC; Chen PL; Yeung CY; Liou BY; Chen HL
    J Formos Med Assoc; 2023 Jul; 122(7):648-652. PubMed ID: 36964102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics.
    Smith NF; Marsh S; Scott-Horton TJ; Hamada A; Mielke S; Mross K; Figg WD; Verweij J; McLeod HL; Sparreboom A
    Clin Pharmacol Ther; 2007 Jan; 81(1):76-82. PubMed ID: 17186002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients.
    Boivin AA; Cardinal H; Barama A; Naud J; Pichette V; Hébert MJ; Roger M
    Drug Metab Pharmacokinet; 2013; 28(3):274-7. PubMed ID: 23149872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of SLCO1B3 drives taxane resistance in prostate cancer.
    de Morrée ES; Böttcher R; van Soest RJ; Aghai A; de Ridder CM; Gibson AA; Mathijssen RH; Burger H; Wiemer EA; Sparreboom A; de Wit R; van Weerden WM
    Br J Cancer; 2016 Sep; 115(6):674-81. PubMed ID: 27537383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants of SLCO1B7 are of relevance for the transport function of OATP1B3-1B7.
    Meyer Zu Schwabedissen HE; Seibert I; Grube M; Alter CL; Siegmund W; Hussner J
    Pharmacol Res; 2020 Nov; 161():105155. PubMed ID: 32818652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation.
    Fujimoto N; Kubo T; Inatomi H; Bui HT; Shiota M; Sho T; Matsumoto T
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):336-40. PubMed ID: 23896625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.
    Nambu T; Hamada A; Nakashima R; Yuki M; Kawaguchi T; Mitsuya H; Saito H
    Biol Pharm Bull; 2011; 34(1):114-9. PubMed ID: 21212528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
    Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequencies of single-nucleotide polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 genes in a Finnish population.
    Laitinen A; Niemi M
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):9-13. PubMed ID: 20560925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers.
    Zhang Y; Boxberger KH; Hagenbuch B
    PLoS One; 2017; 12(6):e0180257. PubMed ID: 28644885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.
    Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M
    Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
    Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.
    DeGorter MK; Ho RH; Leake BF; Tirona RG; Kim RB
    Mol Pharm; 2012 Apr; 9(4):986-95. PubMed ID: 22352740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.
    Hartkoorn RC; Kwan WS; Shallcross V; Chaikan A; Liptrott N; Egan D; Sora ES; James CE; Gibbons S; Bray PG; Back DJ; Khoo SH; Owen A
    Pharmacogenet Genomics; 2010 Feb; 20(2):112-20. PubMed ID: 20051929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.
    Imai S; Kikuchi R; Tsuruya Y; Naoi S; Nishida S; Kusuhara H; Sugiyama Y
    Pharm Res; 2013 Nov; 30(11):2880-90. PubMed ID: 23812637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P; Singh N; Sharma S
    J Clin Pharm Ther; 2022 Dec; 47(12):2049-2067. PubMed ID: 35896189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
    Chew SC; Singh O; Chen X; Ramasamy RD; Kulkarni T; Lee EJ; Tan EH; Lim WT; Chowbay B
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
    Dayal JH; Cole CL; Pourreyron C; Watt SA; Lim YZ; Salas-Alanis JC; Murrell DF; McGrath JA; Stieger B; Jahoda C; Leigh IM; South AP
    J Cell Sci; 2014 Feb; 127(Pt 4):740-51. PubMed ID: 24357722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
    Lee W; Belkhiri A; Lockhart AC; Merchant N; Glaeser H; Harris EI; Washington MK; Brunt EM; Zaika A; Kim RB; El-Rifai W
    Cancer Res; 2008 Dec; 68(24):10315-23. PubMed ID: 19074900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancer.
    Pratt E; Sissung TM; Figg WD
    Cancer Biol Ther; 2012 Dec; 13(14):1374-5. PubMed ID: 22954695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.